NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Portfolio Pulse from
The Schall Law Firm has announced a class action lawsuit against Intellia Therapeutics, Inc. for alleged securities fraud. Investors who purchased Intellia's securities between July 30, 2024, and January 8, 2025, are encouraged to join the lawsuit before April 14, 2025.
March 14, 2025 | 8:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The announcement of a class action lawsuit for securities fraud is likely to create negative sentiment among investors, potentially leading to a decline in Intellia's stock price. Legal issues can impact investor confidence and result in increased volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100